AbbVie (NYSE:ABBV) agreed to a three year voluntary drug affordability deal with the US government, paired with a pledge to invest $100b in R&D. The company is expanding its direct to patient drug ...

UniQure had planned to seek accelerated approval for AMT-130 early 2026, but then said its plans were stalled after ...

Topline data were announced from two phase 3 trials evaluating amlitelimab for the treatment of moderate to severe atopic dermatitis.

More than one-third of patients with cutaneous chronic graft-versus-host disease had a perception of treatment response that ...

A daily preventive pill can be invaluable for people at risk for HIV. But some doctors don't know much about prescribing them and billing headaches are common. Here’s how to overcome those ...

More than 4,400 lawsuits have been filed since millions of Americans embraced GLP-1 drugs like Ozempic, Wegovy and Mounjaro ...

Ontario teacher Amy Miller was told she would lose coverage for a drug she relies on to manage a painful condition unless she ...

Cannabis-based medicines have been widely promoted as a potential answer for people living with chronic nerve pain—but a ...

SaveHealth reports on common rheumatoid arthritis medications, highlighting their effectiveness, side effects, and cost ...

While Dr. Adeel Khan is struggling to keep up with emails ever since Kim Kardashian posted about getting stem cell treatment, he does warn others about relying on celebrity reviews. He also opens up ...

AUSTIN (KXAN) – Next year, Texas will be one of six states participating in a Medicare pilot program that uses artificial intelligence to review certain patient service requests to reduce fraud, waste ...